Providence Medical Technology rakes in $6.8 mln Series C funds
Providence Medical Technology has received $6.8 million in Series C financing. Stanmore Medical Investments led the round with participation from Aphelion Capital and RCT Ventures. Also, Stanmore's David Cash and Aphelion's Ned Scheetz have been added to Providence's board of directors. Based in Lafayette, Calif., Providence Medical Technology is a medical device company focused on the cervical spine market.
1 April 2014•2 mins read
